Around Fox Chase

Before he was a surgeon specializing in breast cancer at Fox Chase Cancer Center, Austin Williams, MD, MSEd, FACS, was teaching chemistry at William Penn High School in North Philly.

Since 2019, Heather Morgan has navigated three cancer diagnoses across multiple states, gaining firsthand experience in compassionate, coordinated care.

Roland L. Dunbrack Jr., PhD, Professor and Co-leader of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center and Founding Director of the Fox Chase Molecular Modeling Facility, has been honored with the 2026 DeLano Award for Computational Biosciences from the American Society for Biochemistry and Molecular Biology (ASBMB).

Several new endowed chairs were awarded at Fox Chase Cancer Center this year, including David Y.T. Chen, MD, FACS, who was named the Carol and Louis Della Penna Chair in Urologic Oncology.

Mitchell Fane, PhD, Assistant Professor in the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, was recently awarded a three-year, $600,000 Early Career grant from the V Foundation, an organization dedicated to accelerating cancer research and treatment.

The two-year fellowship supports Guilbaud’s research, which seeks to strengthen the immune system’s response to breast cancer following radiation therapy.

Fox Chase Cancer Center announced that David Weinberg, MD, MSc, has been appointed as Vice President/Physician Lead of the Cancer Screening and Prevention Service Line and Associate Director of Cancer Screening and Prevention for the Institute for Cancer Research.

Amanda Purdy, PhD, Associate Chief Academic Officer and Director of Academic Affairs at Fox Chase Cancer Center, Temple Health, served as a panelist for “Powering Research: How cutting-edge research and innovation are critical to the region and businesses.” The discussion examined how discovery translates into companies, therapies, workforce development, and community impact.